PNC Financial Services Group’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
Other funds holding MCRB
FP
PNC Financial Services Group's MCRB Position: Q1 2025 in Review
PNC Financial Services Group sold out of Seres Therapeutics (MCRB) in Q1 2025, closing a stake of 32 shares — an estimated $529 sold.
PNC Financial Services Group first reported a position in MCRB in Q3 2015 and held it in 14 quarters. The position peaked at $4.28K in Q3 2023. 63 funds tracked by Wall St. Rank hold MCRB as of Q1 2025.
- PNC Financial Services Group reported no remaining Seres Therapeutics position as of Q1 2025 after selling out during the quarter.
- PNC Financial Services Group sold 32 Seres Therapeutics shares in Q1 2025, an estimated $529.
- PNC Financial Services Group first reported a position in Seres Therapeutics in Q3 2015 and held it in 14 quarters.
- PNC Financial Services Group's Seres Therapeutics position peaked at $4.28K in Q3 2023.
- 63 funds tracked by Wall St. Rank held Seres Therapeutics as of Q1 2025.
Based on PNC Financial Services Group's 13F filing for Q1 2025, filed 9 May 2025.